Circulating tumor DNA detection (liquid biopsy): prospects in oncology by N. V. Zhukov, A. R. Zaretskiy, S. A. Lukyanov, S. A. Rumyantsev

Subjects: “…circulating tumor dna…”
Get full text

DNA methylation profiling for molecular classification of neuroblastoma by Maja Löfgren, Anna Djos, Shiva Rezaei, Medha Suman, Per Kogner, Tommy Martinsson, Susanne Fransson, Helena Carén

“…We investigated the utility of DNA methylation-based classification for neuroblastoma diagnostics by analysing 303 tumours samples from two cohorts. …”
Get full text

Toward the DNA methylation haplotype map of 11 common solid cancers by Zhiqiang Zhang, Yuyang Hong, Shirong Zhang, Xin Zhu, Leiqin Liu, Xiqi Liao, Hongcang Gu, Hai Fang, Jiantao Shi

Get full text

DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasis by Christine Aaserød Pedersen, Thomas Fleischer, Maximilian Wess, Elise Midtbust, Maria K. Andersen, Trond Viset, Øystein Størkersen, Morten B. Rye, May-Britt Tessem

“…In this study, we analyzed DNA methylation in 64 prostate cancer tissue samples, using tissue from radical prostatectomy patients (n = 16) with up to 16 years of clinical follow-up. …”
Get full text

CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY by I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky

“…Therefore, pharmacological increase of DNA methylation may be an effective treatment strategy which may exert pleiotropic effects in diabetes-associated OA. …”
Get full text

Epigenetic changes in patients with post-acute COVID-19 symptoms (PACS) and long-COVID: A systematic review by Madhura Shekhar Patil, Emma Richter, Lara Fanning, Jolien Hendrix, Arne Wyns, Laura Barrero Santiago, Jo Nijs, Lode Godderis, Andrea Polli

“…Results Eight studies were included in our review. Six studies explored DNA methylation in PACS and/or long-COVID, while two studies explored miRNA expression in long-COVID associated with lung complications. …”
Get full text

Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma by An Wang, Yun-ye Mao, Tao Li, Xin Zhou, Yi-bing Bai, Jia-pei Qin, Yi Dong, Ting Wang, Tong Zhang, Zhi-qiang Ma, Yi Hu

“…We comprehensively analyzed its correlation with six genomic instability markers and the DNA methylation- and mRNA-based stemness index in certain tumors to investigate the potential role of NCOA4 in mediating cancer genomic heterogeneity and stemness. …”
Get full text